awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q48401064-70969FC1-18D5-4627-886D-3F097D2B34E3
Q48401064-70969FC1-18D5-4627-886D-3F097D2B34E3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48401064-70969FC1-18D5-4627-886D-3F097D2B34E3
Three-year follow-up of advanced melanoma patients who received ipilimumab plus fotemustine in the Italian Network for Tumor Biotherapy (NIBIT)-M1 phase II study.
P31
Q48401064-70969FC1-18D5-4627-886D-3F097D2B34E3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48401064-70969FC1-18D5-4627-886D-3F097D2B34E3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e2487dcb46bd037bf115fde2c0c769da239ef983
P31
scholarly article